The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1484
December 21, 2015
View Complete Issue         Table of Contents 2019 
Intravenous Diclofenac (Dyloject)
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Intravenous Diclofenac (Dyloject)
December 21, 2015 (Issue: 1484)
The FDA has approved Dyloject (Hospira), an IV formulation of the NSAID diclofenac sodium, for use in adults. It can be administered alone for treatment of mild to moderate pain or in combination with opioid analgesics for moderate to severe...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Intravenous Diclofenac (Dyloject)
Article code: 1484b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.